Webinars & Presentations Seminar: Broad Institute Cell Engineering

High Efficiency Cell Engineering Seminar - Hosted at The Broad Institute

Join us at The Broad Institute for an insightful seminar hosted by MaxCyte

Thursday May 16, 2024
12:00 - 1:00 PM (EST)

In-Person Event
Broad Institute
75 Ames Street
Cascades Conference Room
Cambridge, MA 02142

About the seminar

Join us for an exciting cell engineering seminar on Thursday May 16, 2024 from 12:00-1:00 pm at the Broad Institute!

Register to hear how guest speaker Vimal Keerthi from Stanford University's Cell Therapy Center leverages the MaxCyte platform to manufacture gene engineered products for patients. You will also gain valuable insights into how MaxCyte ExPERT innovative electroporation platform enables the efficient engineering of primary cells, stem cells, and many more cell lines.

Discover how our technology guarantees high cell viability and optimal recovery rates for a wide range of applications, including CRISPR, cell-based assays, cell therapy manufacturing, viral production, and so much more.

Lunch will be on us: We value your time, and to keep the focus on learning, we're providing a complimentary breakfast for all in-person attendees.

RSVP by filling out this form to secure your seat!

Speakers

Vimal Keerthi

Process Development Scientist at Dr. Steven Feldman’s Lab, Stanford Laboratory of Cell and Gene Medicine Stanford Center for Cancer Cell Therapy

Vimal is a Process Development Scientist in Dr. Steven Feldman’s group at the Stanford Center for Cancer Cell Therapy focusing on developing CRISPR knock-in platforms for non-viral CAR-T manufacturing. Prior to working on non-viral platforms, Vimal worked on the process development of Allogeneic Hematopoietic Stem Cell Transplants and donor derived T-allo10 Tr1 cell therapies at Stanford’s cGMP Laboratory of Cell & Gene Medicine.

Leif Anderson, PhD

Field Application Scientist
MaxCyte, Inc.

Leif Anderson is a Senior Field Application Scientist at MaxCyte. Leif is a trained biomedical engineer with years of experience working with primary cells, including iPSC’s at the Salk Institute and hematopoietic stem cells at UC Davis. Leif’s professional experience prior to joining MaxCyte includes supporting product development and commercialization of gene therapy products at LUMICKS, Nanoview Biosciences, and Unchained Labs.

Jess keeley

Business Development Manager
MaxCyte, Inc.

Jess holds a degree in Biology from the University of Pittsburgh and has built a robust career in biotechnology. With roles at renowned companies such as Thermo Fisher, Biotage, and MaxCyte, he has extensively supported both industry and academic research labs in their cell therapy, gene therapy, and drug discovery workflows. Currently, Jess serves as the Strategic Business Manager for MaxCyte, overseeing the Northeast US and Eastern Canada regions.